Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yishen Xingyang capsule (益肾兴阳胶囊) is a traditional Chinese medicine (TCM) developed and manufactured by Beijing Yushengtang Pharmaceutical. It is an NMPA-approved oral medication primarily indicated for the treatment of kidney-yang deficiency, a condition in TCM characterized by symptoms such as impotence, premature ejaculation, decreased libido, and physical fatigue. The formulation is a complex mixture of herbal and animal-derived ingredients, including Epimedium, Rehmannia, Lycium, and Deer Antler, which are traditionally used to tonify the kidneys and replenish vital energy (Yang). It is widely used in China to improve male reproductive health and overall vitality.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yishen xingyang jiaonang.